U.S. Vaccine Panel Delays Vote on J&J Covid-19 Shot’s Blood-Clotting Risk

U.S. Vaccine Panel Delays Vote on J&J Covid-19 Shot’s Blood-Clotting Risk

The federal government’s recommendation to pause using Johnson & Johnson’s Covid-19 vaccine will remain in place after an advisory panel put off a vote on how to move forward following reports of a few cases of life-threatening blood clots.